MiR-29a efficiently suppresses the generation of reactive oxygen species and α-synuclein in a cellular model of Parkinson's disease by potentially targeting GSK-3β
Article in European Journal of Pharmacology (April 2024)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Article in European Journal of Pharmacology (April 2024)
Article in Frontiers in Immunology (November 2023)
Article in Bioengineering (July 2023)